Three spots in human genome could predict whether aspirin is good or bad for colorectal cancer risk

Researchers have identified two single nucleotide polymorphisms (SNPs) that can provide differential benefit for aspirin use in relation to colorectal cancer risk.

It is well known that aspirin or nonsteroidal anti-inflammatory drug (NSAID) can reduce the risk of colorectal cancer. But doctors were reluctant to use NSAIDs for cancer prevention without a better understanding of why the drugs seem to work.

The reason was that for some people the same pills make colorectal cancer more likely. The research was done to know how to separate people who will be benefitted from asprin and those who won't be. The researchers looked at three specific spots in the vast human genome to find this out.

Diet Soda is linked to Belly Fat: Study

If you are a soda lover, it could be really sad for you to know that diet soda could make you fat. According to a new study conducted by researchers from the University of Texas Health Science Center, an individual who drinks soda gains three times as much waist as a non-drinker.

The study, published in Journal of the American Geriatrics Society, studied the effects of drinking diet sodas regularly. The study had included seniors or those who were already 65 years old and above.

Zydus Cadila Launches Generic Version of Gilead Sciences’ Hepatitis C drug in India

Pharmaceutical companies across the globe have been spending lot of money in research to find out effective treatments for Hepatitis C. In India, more than 10 million people suffer from Hepatitis C, which was earlier considered to be an incurable problem.

Today, Zydus Cadila has launched a generic version of Gilead Sciences’ Hepatitis C drug Sofosbuvir in India. The drug has been launched under the brand name ‘SoviHep’. Both the companies, Zydus and Gilead Sciences, have signed a non-exclusive licensing agreement.

As per the agreement, manufacturing of Gilead Sciences’ Hepatitis C drug Sofosbuvir can be done and also allows the distribution of fixed-dose combination of ledipasvir/sofosbuvir in 91 countries even in India.

Social Isolation causes premature death: Study

A new study conducted by psychologists at Brigham Young University has revealed about the concept of a healthy life.

According to the researchers, social isolation and solitude can be a cause of premature death. Although older people are more prone to feeling lonely and possess a higher risk of mortality, social isolation and solitude can also cause early death in people who are less than 65 years old.

Other studies conducted on the same issue indicated that for sound emotional health, social interaction is important as it improves physical health on a physiological level.

Glaxo’s asthma treatment under review

According to Reuters, GlaxoSmithKline Plc’s new respiratory treatment for chronic breathing problems is being reviewed to ensure the safety of the drug over long term use to treat asthma patients.

According to the US Food and Drugs Administration (FDA), they are conducting review of the treatment and are also carrying out the discussion on approval of the combination treatment, Breo Ellipta.

The agency has already approved the inhaled drug combination of vilanterol and corticosteroid for treatment of chronic obstructive pulmonary disease, which is a breathing disability. It becomes severe over time and generally smokers are only affected by it.

Breastfeeding may Boost Baby’s IQ

A long-term study has indicated an association between breastfeeding and intelligence. The research was done in Brazil, where the researchers traced around 3,500 babies, from all walks of life, and found that those who had been breastfed for longer went on to score higher on IQ tests as adults.

The experts have said that the results, while not convincing, have appeared to back current advice that babies should be completely breastfed for six months. But still, they mentioned that the mothers should have a choice about whether or not to do it.

Pages

News in Focus

Nvidia (NVDA) Stock Price Could Reach $300 as per Bernstein’s David Dai; Nasdaq Composite at Record Highs

Nvidia continues to command the narrative in global technology markets, with Bernstein reaffirming its bullish stance and projecting a $300 price target, anchored by the transformative potential o

Nasdaq Composite Closes at All-Time Highs; Nvidia Stock Price Above $200, Tesla Closes 3% Higher

Nasdaq Composite Closed at all-time highs as investors turned bullish on Iran-US talks to end the war.

HDFC AMC Share Price Target at Rs 3,063: Deven Choksey Research

Deven Choksey Research has reiterated an ACCUMULATE stance on HDFC Asset Management Company, highlighting that the recent earnings miss is largely optical and driven by one-off treasury adjustments

ICICI Prudential Life Insurance Share Price Target at Rs 650: Motilal Oswal

Motilal Oswal Financial Services has reiterated a BUY call on ICICI Prudential Life Insurance with a target price of Rs 650, implying an upside of ~19% from the current market pric

Nasdaq Composite Closes at All-Time Highs; Tesla Stock Price Jumps 7.6%, MSFT Stock Gains 4.6

The Nasdaq Composite has surged into record territory, signaling a renewed wave of bullish momentum driven largely by heavyweight technology stocks.